Back to Authors

O’Neill, Heather A.

A5070357958 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 3

Assembly of Human Frataxin Is a Mechanism for Detoxifying Redox-Active Iron

Biochemistry | January 11, 2005 | Volume: 44 | Issue: 2 | Pages: 537-545

10.1021/bi048459j | PMID 15641778

Frataxin Acts as an Iron Chaperone Protein to Modulate Mitochondrial Aconitase Activity

Science | July 8, 2004 | Volume: 305 | Issue: 5681 | Pages: 242-245

10.1126/science.1098991 | PMID 15247478

Numerous degenerative disorders are associated with elevated levels of prooxidants and declines in mitochondrial aconitase activity. Deficiency in the mitochondrial iron-binding protein frataxin results in diminished activity of various mitochondrial iron-sulfur proteins including aconitase. We found that aconitase can undergo reversible citrate-dependent modulation in activity in response to pro-oxidants. Frataxin interacted with aconitase in a citrate-dependent fashion, reduced the level of oxidant-induced inactivation, and converted inactive [3Fe-4S] 1+ enzyme to the active [4Fe-4S] 2+ form of the protein. Thus, frataxin is an iron chaperone protein that protects the aconitase [4Fe-4S] 2+ cluster from disassembly and promotes enzyme reactivation.
Structure of Frataxin Iron Cores:  An X-ray Absorption Spectroscopic Study

Biochemistry | May 20, 2003 | Volume: 42 | Issue: 20 | Pages: 5971-5976

10.1021/bi027021l | PMID 12755598